Ovarian Ageing and Fertility

Slides:



Advertisements
Similar presentations
The Diagnosis and Treatment of Infertility
Advertisements

How Old is Too Old? Age, Genetics and Reproduction
In Vitro Fertilization
New Developments in Assisted Reproduction
Jisha Rajendran Keay SD et al. BJOG
Physiology of menstruation
Premature Ovarian Aging and Infertility
‘President’s Medal’ for best medical graduate ‘Dr. B.C Roy’s award’ in 1999 for outstanding contribution towards medicine and field of specialty,
ART-IVF: the Long and Short of it Professor Ernest Hung Yu NG Department of Obstetrics & Gynaecology The University of Hong Kong.
Elonva in poor responders
Approach in infertile couple
The McCoughey Septuplets. Infertility 101 Definitions Under 35 yoNo conception after one year of unprotected intercourse Over 35 yoNo conception after.
Minimal Monitoring of Ovulation Induction (OI) Is It Safe? Mustafa Uğur Zekai Tahir Burak Women’s Health Education and Research Hospital, Ankara, Turkey.
INDIVIDUALIZED IVF TREATMENT
Breast Cancer, Fertility and Pregnancy
Ovarian reserve and infertility
Infertility 101 Dana Ambler, DO Director, Donor Egg Program Associate Physician Conceptions Reproductive Associates.
Aging and Female Fertility
Emily Bartlett Katrina Bush
The Effect of PCOS Treatment on Ovarian Function
Anti-Mullerian Hormone in the pathophysiology of PCOS Roy Homburg Homerton University Hospital, London & Barzilai Medical Centre, Ashkelon, Israel.
Role of Anti-Mullerian hormone in prediction of Assisted Reproductive Technology outcomes Leili Safdarian M.D. Khadigeh Khosravi M.D. Marzieh Agha Hosseini.
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture By: Reem Sallam, MD, MSc, PhD.
Insulin sensitizing agents use in pregnancy and as therapy in PCOS
IVM is ready as a treatment for PCOS patients
Discontinuation of rLH two days before hCG may increase the number of oocytes retrieved in IVF Jessica B Spencer 1*, Aimee S Browne 1, Susannah D Copland.
Ovaries and the Fertility Cycle
THE IMPACT OF FEMALE OBESITY ON IN VITRO FERTILIZATION OUTCOMES Prof. Dr. İdris KOÇAK ONDOKUZ MAYIS UNIVERSITY DEPARTMENT OF OBSTETRICS AND GYNECOLOGY,
IVF update Dr Gregory Jenkins VMO Norwest Private Hospital VMO Sydney West AHS Accredited Specialist Genea.
Infertility Grand Challenge Seminar Fall, What is infertility? Infertility is the term health care providers use for women of normal childbearing.
ART Assisted reproductive technology Dithawut Khrutmuang MD.
Results Premature Ovarian Deficiency in HIV-infected women Marialuisa PARTISANI 1,2, Jeanine OHL 2, Christine DEMANGEAT 3, Florence BINDER-FOUCARD 4, Israël.
TEMPLATE DESIGN © Oocyte donation outcomes at Alpha International Fertility Centre IntroductionResultsConclusions References.
Infertility Parenting. What is Infertility? n Not being able to get pregnant after at least one year of trying. n Women who are able to get pregnant but.
Planning of GnRH antagonist cycles
Dr. Milton Leong Director
The 4th Misurata scientific meeting of infertility Benghazi – Libya 10/10/2008 Dr. Omar A. Elsraiti Consultant of Obst. & Gyn. IVF Centre - Misurata /
REFERENCES Infertility, 2 nd ed 1997 : Machelle M.Seibel Human Reprod Update 1996;2: Maturitus 1998;30:103-4 Maturitus 1998;30: Maturitus.
SL ‘00 Antagonists in patients with previous poor ovarian response Antagonists in patients with previous poor ovarian response Geoffrey H Trew Consultant.
Agonist vs Antagonist Dr. Milton Leong.
Recommended Dosage of GnRH Antagonist is Too High Presented by Dr. Milton Leong, MD DSc(McGill) Director, IVF Centre.
The Challenge of the Miracle of Life - Infertility Jennifer McDonald DO.
Infertility. Fertility Sub fertility Sterility Infertility:Diminished capacity to conceive and bear a child Sterility:Absolute and irreversible inability.
Biology, Grade 12 SBI4U Female Reproductive System.
IVF TROUBLESHOOTING ( Clinical Perspective) Malvin Emeraldi M. Luky, Dianing ASR,Muchsin J Family Fertility Center, RSIA Family Fatmawaty Hospital Jakarta,
Konstantin Y. Boyarsky1,2, MD, PhD
Fertility Facts Definition:unprotected sex for one year, not pregnant
Role of decreased androgens in the ovarian response to stimulation in older women Fertil Steril Jan;99(1):5-11 Presented by Hsing-Chun Tsai
Biology 12 THE FEMALE MENSTRUAL CYCLE.  The menstrual cycle is the term for the physiological changes that can occur in fertile women for the purposes.
Biology 105 Chapter 50: Reproduction Pages Chapter 50: Reproduction Pages
An analysis of 2,566 cycles Premature progesterone rise negatively correlated with live birth rate in IVF cycles with GnRH agonist: An analysis of 2,566.
Vikram Talaulikar, Melanie Davies & Gerard S Conway
Facilitator: Pawin Puapornpong
Mohamed Elmahdy MD. Lecturer Obs. Gyn. Alexandria University Egypt
Polycystic ovarian syndrome Obesity and Insulin resistance
The long-term effect of endometrioma surgery on ovarian reserve:
Menopause Professor Susan Davis Women’s Health Program
Pregnancy outcomes after assisted reproductive procedures of embryos derived from affected and unaffected ovaries among women with small unilateral endometriomas.
Reproduction-Related Disorders
Aging and Infertility. Part 2. National Infertility Centre
Infertility Parenting.
The effect of the duration of stimulation on ART outcomes
Antagonists in poor-responder patients
Patient-tailored ovarian stimulation for in vitro fertilization
Biomarkers of ovarian response: current and future applications
Polycystic ovary syndrome (PCOS) is extremely prevalent and probably constitutes the most frequently encountered endocrine (hormone) disorder in women.
Comparison of antimüllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis.
Dr. Kenneth Egwuda MBBS, PGA-ART(Lon), ESGE(Belg.),FMAS,FWACS,FMCOG
Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis.
Presentation transcript:

Ovarian Ageing and Fertility Dr. Sharda Jain Secretary General Delhi Gynaecologist Forum HOD, Puspanjali Crosslay Hospital

Reproductive organs Ovary Uterus Passive organ Responds to endogenous or exogenous hormones for ever No senescence Active organ with fixed deposit of oogonia at birth Once fixed deposit is over no response to endogenous or exogenous hormones menopause

Why ovarian ageing? Birth: 1-2 million oogonia Puberty: 3 to 5 lac oogonia menopause: Follicular exhaustion (number of resting follicles below 1000) ovulation500 atresia3-5 lac In healthy woman accelerated loss & accelerated qualitative decline of follicles start at 37.5 years when only 25000 resting follicles remain in ovaries. Fertility , both natural and assisted, declines rapidly after 37.5 years and almost becomes zero at age 41.

DIAGNOSIS OF POOR RESPONDERS RETROSPECTIVE TWO ATTEMPS OF COH IN SUPEROVULATION PROTOCOLS <3 DOMINANT FOLLICLES E2 LEVELS OF < 1000 PG/ML.

PROFILE OF POOR RESPONDER age> 35yrs Unexplained infertility Clinical history consistent with previous ovarian damage Prior cycle cancellation due to poor response Women nearing end of reproductive life and having menstrual problems

Other causes of premature ovarian ageing (poor responder)? H/o Early menaupause (F/H) Smoking Pelvic inflammatory disease Endometriosis Chemotherapy Pelvic surgery and not just ovarian surgery HIV and hepatitis Prolonged use of ocp! myth?

Types of Tests to Predict Ovarian Ageing CHRONOLOGICAL AGE ENDOCRINE TESTS Basal FSH, E2, FSH:LH ratio, Inhibin B and AMH levels ULTRA-SONOGRAPHY Ovarian volume and AFC DYNAMIC TESTS CCCT GAST EFORT INVASIVE TESTS

AGE ↓ NO. OF OOGONIA & DECLINE IN OOCYTE QUALITY Tietze & Hutterite: women in Canada and USA:11% cease having children at 34 years, 33% no pregnancies after 39years and extremely rare pregnancy after 45 years POOR IMPLANTATION AND ↑ CHANCES OF ABORTION Virro etal.,1984; HIGHER RISK OF GENETIC ABERRATIONS: Lim AST , Fertil Steril 1997: rate of genetic aberration 24% in < 34 years, 52% b/w 35-39 and 95.8% in age > 40 years

D3 FSH ↑10 IU/L are considered ABNORMAL BASAL FSH D3 FSH ↑10 IU/L are considered ABNORMAL - Correlates with fewer available oocytes - Poor outcome with IVF No statistical variation in predictive value of D2 to D5 FSH in regular cycles Fluctuating FSH values indicates poor ovarian reserve

BASAL FSH LARGEST RETROSPECTIVE STUDY OF 758 IVF CYCLES FSH < 15 miu/ml- PR 17%, FSH 15-24.9: PR 9.3% FSH> 25 : PR 3.6% Scott RT , Fertil Steril 1995

D3 Estradiol: > 60 pg/ml BASAL E2 D3 Estradiol: > 60 pg/ml Difficulty in achieving pregnancy Characterstic of years preceding menopause BENEFICIAL IN SCREENING FOR POTENTIAL POOR OVARIAN RESPONDER IN CASES WITH NORMAL FSH VALUE

↓ false negative results BASAL E2 DAY3 E2 CAN VARY AS MUCH AS 40% WHERE AS D2 TO 4 FSH SHOWS ONLY 18% VARIANCE EARLY PREDICTION COMPARED TO BASAL FSH FSH & E2 (combined)- ↓ false negative results

BASAL E2 ≥ 60 pg/ml Liccardi etal , Fertil Steril 1995 NO PREGNANCY with basal E2 >75, Maximum pregnancy with E2< 30 Smotrich etal , Fertil Steril 1995, No Pregnancy with E2>100, lower PR ,↑cancellation with E2 > 80 ≥ 60 pg/ml

FSH: LH FSH: LH> 3 despite normal FSH values may help to identify poor ovarian responder Fewer oocytes retrieved, lower implantation rates, poor clinical PR Barroso G etal 2001; LH / FSH ≥ 2 / PCOS

HIGH LH >10 MIU/ML: INDICATES POOR RESPONSE - PCOD - IR

BASAL INHIBIN B ≤ 45 pg/ml Direct measure of ovarian reserve. levels ≤ 45 pg/ml correlates well with lower PR Seifer et al, Fertil Steril 1997,1999; Danforth et al.,1998; Fried et al.,2003. All studies do not support its use as clinical marker Hall et al.,1999; Creus et al.,2000 Follicles of obese women produce less inhibin B as compared to lean women Low inter-cycle variation compared to FSH ≤ 45 pg/ml

ANTI MULLERIAN HORMONE (AMH) AMH is produced by granulosa cells of small antral follicle till they become sensitive to FSH AMH disappears at menopause or after oopherectomy AMH levels of less than 1.1 associated with IVF failure ANTRAL COUNT

ULTRA-SONOGRAPHY Ovarian volume is an independent predictor of IVF outcome (N-7 cc) Volume <3 cc-predicted 50% cancellation rate Antral Follicle Count: <5 in no- inactive ovaries 5-10 in no: normal >15: PCO

INVASIVE TEST OVARIAN BIOPSY FOR FOLLICLE CONCENTRATION

DYNAMIC TESTS OF OVARIAN RESERVE Clomiphene Citrate challenge test (CCCT) Gonadotropin agonist stimulation test (GAST) Exogenous FSH ovarian reserve test (EFORT) No test absolute Poor prognosis Helps in decision making process.

CLOMIPHENE CITRATE CHALLENGE TEST (CCCT) 100 mg clomiphene D5-9, FSH on D3 and D10: abnormal test defined as abnormally high FSH on D3 and/or D 10 Navot etal 1987 Assesses ovarian reserve in women with intact HPO axis 94% accurate and beneficial in unexplained infertility 2-3 times better pick up rate than basal FSH. Recent meta-analysis shows CCCT equal to basal FSH as predictor. Jain et al 2004

CLOMIPHENE CITRATE CHALLENGE TEST (CCCT) Prevalence of abnormal test – 10% ↑ with - ↑ age ↑ ↑ - unexplained infertility Normal Day 3 FSH & ↑ Day 10 FSH – same poor results as of ↑ Day 3 FSH ≥15-17 MIU/ML ON Day 10 Poor Prognosis - PAI

GnRH AGONIST STIMULATION TEST (GAST) Evaluates change in serum E2 between D2 and D3 after s/c administration of 1 mg of Leuprolide acetate E2 elevation by D2 and decline by D3 had better implantation and PR No rise or persistent elevation : poor implantation and pregnancy rate Padilla etal

EXOGENOUS FSH OVARIAN RESERVE TEST (EFORT) E2 level is assessed on D3 and then 24 hrs after administration of 300 IU of purified FSH Increase in E2> = 30pg/ml predictive of good response in subsequent IVF cycle

HOW TO TREAT POOR RESPONDER? Ovulation induction CC followed /overlap with HMG High dose HMG (4 to 6 amp/day) from day 2-3 GnRH agonist with HMG Short protocol Flare up protocol Mini dose GnRH agonist for long protocol down regulation Antagonist protocol

ADDITIVES TO IMPROVE RESPONSE Growth hormone GH releasing factor

CONCLUSIONS IDEALLY FSH SHOULD <10MIU LH <8MIU E2 <5O PG

CONCLUSIONS FSH >20 MIU NO HOPE WITH DRUGS

FSH 10-20 IU/ML (COMMONLY SEEN AT 35-40 YERS) BODERLINE RESPONSE TO STIMULATION. BUT MOST OF THE CASES MAY NOT RESPOND TO G.T. STIMULATION. LARGER DOSES OF GT HAVE TO BE USED-------- LESS RESPONSE OF OVULATION.

E2 LEVEL >60 PG/ML IT INDICATES FOLLICLE FUNCTIONING AT ACCELERATED LEVELS AND THESE CYCLES OFTEN YIELD OOCYTES OF REDUCED QUALITY.

POOR RESPONDERS >35 YEARS D3 FSH >10 – GUARDED APPROACH - >20 – NO HOPE D3 E2 >60-80 PG/ML FSH: LH >3 D3 LH <3 MIU/ML

POOR RESPONDERS INHIBIN ≤ 45 PG/ML USG O.VOL. <3 CM3/AFC <5 CC CHALLENGE TEST ↑D3 , 10 FSH - ≥ 17 Extremely Poor Response

IVF Patient with diminished ovarian reserve (FSH >15 miu/ul) should be discouraged from undergoing IVF with their own egg. Oocyte donation offers high success rate in cases with >15 FSH and E2 > 80

thank you